About Mimetas
Mimetas is a company based in Leiden (Netherlands) founded in 2013 by Paul Vulto. Mimetas has raised $28.9 million across 21 funding rounds from investors including Cathay Financial Holdings, HHS and European Union. Mimetas operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Nortis and NETRI, among others.
- Headquarter Leiden, Netherlands
- Founders Paul Vulto
- SectorsHealthcare
- Phone•••• ••••
- Website mimetas.com/en/home
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$28.9M (USD)
in 21 rounds
- Latest Funding Round$272.82K (USD), Grant
Sep 2022
- InvestorsCathay Financial Holdings
& 9 more
Apps and channels of Mimetas
its YouTube channel MIMETAS - Human Tissue Models for Better Therapies has 338 subscribers and 30 videos.
Videos from Mimetas
The most watched videos on Mimetas's YouTube channel, MIMETAS - Human Tissue Models for Better Therapies (338 subscribers). Click a video to play it here.
Funding Insights of Mimetas
Mimetas has successfully raised a total of $28.9M across 21 strategic funding rounds. The most recent funding activity was a Grant round of $272.82 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.9M
- Total Rounds 21
- Last Round Grant — $272,823
- Investors Count 10
Latest 10 of 21 funding rounds of Mimetas with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $272,823 | Grant | – | – | |
| Aug 2021 | $58,992 | Grant | – | – | |
| Sep 2020 | $2.23M | Grant | – | – | |
| Jun 2020 | $66,897 | Grant | – | – | |
| Oct 2019 | $304,963 | Grant | – | – | |
| May 2019 | $745,967 | Grant | – | – | |
| Mar 2019 | $2.4M | Grant | – | – | |
| Jan 2019 | $304,422 | Grant | – | – | |
| Nov 2018 | $302,877 | Grant | – | – | |
| Oct 2018 | – | Grant | – | – |
10 investors in total: 10 institutional.
Investors in Mimetas
Mimetas has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Cathay Financial Holdings, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Sustainable investing in conscious consumer, energy transition, and healthy living sectors. | 2011 | korys.be | - | |
Sector-agnostic VC firm investing primarily in the Netherlands | 2013 | innovationquarter.nl | The Hague, Netherlands | |
Sector-agnostic VC firm investing in geographies such as the Netherlands | 2003 | oostnl.nl | Apeldoorn, Netherlands | |
Aglaia Oncology Funds is focused on investing in oncology drug development. | 2004 | aglaia-oncology.com | Bilthoven, Netherlands | |
- | – | zeeuwsinvesteringsfonds.nl | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Life and health insurance company | 1990 | cathayholdings.com | Daan, Taiwan | |
- | – | europeanlifesciencesgrowthfund.tcc.mode | - |
Investor details for Mimetas
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mimetas
27 people are tracked at Mimetas (7 in leadership, 6 in board & advisors, 14 in team).
| Name | Role | Group |
|---|---|---|
Paul Vulto | Co-Founder & Co-CEO | Leadership |
Jos Joore | Co-CEO | Leadership |
Henriëtte Lanz | VP Biology | Leadership |
Bas Trietsch | CTO | Leadership |
Mieke Doornbos | Vice President Sales And Marketing | Leadership |
Shraddha Thakkar | Associate Director Of Sales | Leadership |
Nienke Wevers | Director Biology Services | Leadership |
Edward Willems | Non-Executive Board Member | Board & advisors |
Patrice Denèfle | Scientific Advisor | Board & advisors |
Dhaval Patel | Chairman | Board & advisors |
David Devigne | Non-Executive Board Member | Board & advisors |
Eric Van Der Putten | Non-Executive Board Member | Board & advisors |
André Hoekema | Non-Executive Board Member | Board & advisors |
Bart Kramer | Scientific Project Lead | Team |
Wouter Strijker | Business Development Manager | Team |
Chiwan Chiang | Marketing Specialist | Team |
Meilin Berkhoff | Inside Sales & Support Specialist | Team |
Frederik Schavemaker | Product Design Engineer | Team |
Xandor Spijkers | Scientific Project Lead | Team |
Karla Queiroz | Senior Scientist Application Development | Team |
7 more people are available in the full profile.
Complete people profiles for Mimetas
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mimetas
3 dated milestones of Mimetas across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Mimetas is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $273K.
Competitors of Mimetas
Mimetas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Nortis and NETRI, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| cellboxlabs.com | 2020 | Riga, Latvia | $1.01M | 10 | Organ-on-chip platform is provided for drug discovery and development. | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. |
Detailed competitors of Mimetas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mimetas
The website of Mimetas (mimetas.com) receives about 17.2K visits a month.
- Monthly visits17.2K
▼ 2.9% vs previous month
Websites whose visitors overlap most with Mimetas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| emulatebio.com | 100% | 35.5K | #945,229 | View details | |
| promocell.com | 86% | – | #944,821 | View details | |
ijbs.com | ijbs.com | 82% | – | #341,874 | – |
stw.nl | stw.nl | 64% | – | – | – |
nouvellemesure-lab.com | nouvellemesure-lab.com | 24% | – | #3,943,213 | – |
Latest news on Mimetas
Complete news archive for Mimetas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Mimetas
10 companies that operate in the same segment as Mimetas (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mimetas
Mimetas was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Mimetas is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Paul Vulto is the current CEO of Mimetas. They have also founded this company.
Mimetas is a funded company, having raised a total of $28.9M across 21 funding rounds to date.
Mimetas was founded in 2013 in Leiden, Netherlands, where microfluidics-based organ-on-a-chip tissue models are developed for evaluating drugs, chemicals, and food components. Products such as OrganoPlates, OrganoReady, OrganoTEER, and OrganoFlow are utilized as culture plates for in-vitro tissue culturing. These enable the screening of 3D organ and tissue models to predict toxic side effects, assess drug efficacy, and validate disease, toxicology, and transport models in the biotechnology sector.
Mimetas's top competitors include Emulate, CN Bio and Cellbox Labs.
Mimetas has 10 investors. Key investors include Cathay Financial Holdings, HHS, European Union, Oost NL, and InnovationQuarter.